These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26509484)

  • 1. The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise.
    Martens CR; Kirkman DL; Edwards DG
    Exerc Sport Sci Rev; 2016 Jan; 44(1):12-9. PubMed ID: 26509484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease.
    Martens CR; Kuczmarski JM; Lennon-Edwards S; Edwards DG
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):40-8. PubMed ID: 24084210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.
    Downey RM; Liao P; Millson EC; Quyyumi AA; Sher S; Park J
    Am J Physiol Renal Physiol; 2017 May; 312(5):F917-F924. PubMed ID: 28274927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelium as a target in renal diseases.
    Zoccali C
    J Nephrol; 2007; 20 Suppl 12():S39-44. PubMed ID: 18050141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
    Ueda S; Yamagishi SI; Matsumoto Y; Fukami K; Okuda S
    Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of endothelial dysfunction in chronic kidney disease.
    Malyszko J
    Clin Chim Acta; 2010 Oct; 411(19-20):1412-20. PubMed ID: 20598675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelial injury and CKD].
    Ueda S; Matsumoto Y; Kaida Y; Okuda S; Yamagishi S
    Nihon Rinsho; 2008 Sep; 66(9):1634-8. PubMed ID: 18788387
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity.
    Rush JW; Denniss SG; Graham DA
    Can J Appl Physiol; 2005 Aug; 30(4):442-74. PubMed ID: 16258183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.
    Rajapakse NW; Nanayakkara S; Kaye DM
    Pharmacol Ther; 2015 Oct; 154():1-12. PubMed ID: 25989232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
    Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
    Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voluntary wheel running augments aortic l-arginine transport and endothelial function in rats with chronic kidney disease.
    Martens CR; Kuczmarski JM; Kim J; Guers JJ; Harris MB; Lennon-Edwards S; Edwards DG
    Am J Physiol Renal Physiol; 2014 Aug; 307(4):F418-26. PubMed ID: 24966085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
    Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
    PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction and vascular disease in later life.
    Virdis A; Ghiadoni L; Giannarelli C; Taddei S
    Maturitas; 2010 Sep; 67(1):20-4. PubMed ID: 20452737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial.
    Van Craenenbroeck AH; Van Craenenbroeck EM; Van Ackeren K; Vrints CJ; Conraads VM; Verpooten GA; Kouidi E; Couttenye MM
    Am J Kidney Dis; 2015 Aug; 66(2):285-96. PubMed ID: 25960303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
    Chan NN; Chan JC
    Diabetologia; 2002 Dec; 45(12):1609-16. PubMed ID: 12488950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Asymmetric dimethylarginine and endothelial dysfunction].
    Yoshizumi M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():555-60. PubMed ID: 15506448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.